These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 11550301

  • 21. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U, Rüedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME.
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
    [Abstract] [Full Text] [Related]

  • 22. Genetic pathways to glioblastoma: a population-based study.
    Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
    Cancer Res; 2004 Oct 01; 64(19):6892-9. PubMed ID: 15466178
    [Abstract] [Full Text] [Related]

  • 23. The definition of primary and secondary glioblastoma.
    Ohgaki H, Kleihues P.
    Clin Cancer Res; 2013 Feb 15; 19(4):764-72. PubMed ID: 23209033
    [Abstract] [Full Text] [Related]

  • 24. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
    Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC.
    Brain Pathol; 1998 Oct 15; 8(4):655-67. PubMed ID: 9804374
    [Abstract] [Full Text] [Related]

  • 25. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW.
    Brain Pathol; 2000 Apr 15; 10(2):249-59. PubMed ID: 10764044
    [Abstract] [Full Text] [Related]

  • 26. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 15; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 27. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
    Cheng Y, Ng HK, Ding M, Zhang SF, Pang JC, Lo KW.
    J Neuropathol Exp Neurol; 1999 Feb 15; 58(2):120-8. PubMed ID: 10029095
    [Abstract] [Full Text] [Related]

  • 28. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS, Lee MC, Kang SS, Kim JH, Jung S, Kim YJ, Lee JH, Ahn KY, Lee JS, Cheon JY.
    J Korean Med Sci; 2001 Aug 15; 16(4):481-8. PubMed ID: 11511795
    [Abstract] [Full Text] [Related]

  • 29. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 30. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 15; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 31. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets.
    Ghimenti C, Fiano V, Chiadò-Piat L, Chiò A, Cavalla P, Schiffer D.
    J Neurooncol; 2003 Jan 15; 61(2):95-102. PubMed ID: 12622447
    [Abstract] [Full Text] [Related]

  • 32. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT, Torrieri R, Mackay A, Almeida GC, Viana-Pereira M, Cruvinel-Carloni A, Spina ML, Campanella NC, Pereira de Menezes W, Clara CA, Becker AP, Jones C, Reis RM.
    G3 (Bethesda); 2016 Jul 07; 6(7):1867-78. PubMed ID: 27172220
    [Abstract] [Full Text] [Related]

  • 33. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 07; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 34. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 07; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 35. Genetic pathways to glioblastomas.
    Ohgaki H.
    Neuropathology; 2005 Mar 07; 25(1):1-7. PubMed ID: 15822813
    [Abstract] [Full Text] [Related]

  • 36. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinge G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K.
    J Neurooncol; 2005 Apr 07; 72(2):115-22. PubMed ID: 15925990
    [Abstract] [Full Text] [Related]

  • 37. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G.
    Clin Cancer Res; 2001 Sep 07; 7(9):2788-96. PubMed ID: 11555594
    [Abstract] [Full Text] [Related]

  • 38. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP.
    Cancer Res; 2000 Jan 15; 60(2):417-24. PubMed ID: 10667596
    [Abstract] [Full Text] [Related]

  • 39. Genetic profile of the giant cell glioblastoma.
    Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1999 Feb 15; 79(2):123-9. PubMed ID: 10068201
    [Abstract] [Full Text] [Related]

  • 40. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G.
    J Neuropathol Exp Neurol; 2002 Dec 15; 61(12):1092-9. PubMed ID: 12484572
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.